Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial

By sjmartinez • May 15, 2024

Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ; ACTIV-2/A5401 Study Team. Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial. Pathog Immun. 2024 May 6;9(1):138-155. doi: 10.20411/pai.v9i1.660. PMID: 38746756; PMCID: PMC11093219.

Tags: covid-19, Harbor UCLA, Infectious Diseases, Monoclonal antibodies, outpatient treatment, Publications, SARS-CoV-2, subcutaneous

Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3-5: A randomized controlled trial protocol

Kharma JA, Sultan R, Rizk R, Haroun D, Kilani H, Kalantar-Zadeh K, Gubbels J, Bessems K. Plant-dominant low-protein diet versus standard care in adults with[...]

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19

Kung E, Deo R, Choudhary MC, Chew KW, Evering TH, Ignacio RB, Jagannathan P, Flynn JP, Regan J, Moser C, Giganti MJ, Hughes MD, Ritz[...]

Pregnancy in Patients With Renal Transplant

Elali I, Nelson CK, Szymanski LM, Lemke AI, Riad SM, Hinojosa RJ, Kattah AG. Pregnancy in Patients With Renal Transplant. O G Open. 2026 May[...]